GOV.UK
Blood sample quality in fetal anomaly screening
Important reminders about ensuring NHS Fetal Anomaly Screening Programme samples are taken, stored and transported correctly.
laboratories
Honour from the Queen for inspirational national blood spot screening lead
PHE's newborn blood spot programme manager has praised her 'inspirational' colleague Professor Jim Bonham for his well-deserved MBE.
Best practice screening guidance for pregnancies resulting from egg or sperm donation
This blog article gives providers guidance on sickle cell and thalassaemia screening for women who are pregnant via egg donation.
Guidance for laboratories providing HPV testing and cytology services now available
We are pleased to announce the publication of new guidance for laboratories that are providing human papillomavirus (HPV) testing and cervical cytology services for the NHS Cervical Screening Programme. Please note that an incorrect version of the new guidance for …
GP-endorsed text reminders help increase cervical screening attendance in London
A 6-month trial in London shows that text message reminders can help increase the number of women taking up the offer of cervical screening by nearly 5%.
Successful IDPS laboratory workshop will now be held every year
The NHS Infectious Diseases in Pregnancy Screening (IDPS) Programme held its first ever national workshop for screening laboratory staff.
Reminder about fetal anomaly screening laboratory letters
A reminder for antenatal screening laboratories to use the standard templates to let pregnant women know about low chance fetal anomaly screening results.
We’ve made changes to the family origin questionnaire (FOQ)
Details of the February 2019 changes and improvements to the sickle cell and thalassaemia screening family origin questionnaire.
Roll-out of IT system to collect newborn outcome data begins in earnest
Newborn screening laboratories have started to use a new IT system that provides oversight of screen-positive babies from screening to specialist care.
New HPV implementation guidance for cervical screening providers
We have published new guidance for local cervical screening providers on implementing high-risk human papillomavirus (hrHPV) testing as the programme’s primary screening test.